Effects of Combined Alcohol and Nitrous Oxide Intake - 15

NCT ID: NCT00000263

Last Updated: 2015-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

1997-01-31

Study Completion Date

1998-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the effects of combined alcohol and nitrous oxide intake on mood, psychomotor performance, and the pain response in healthy volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid-Related Disorders Substance-Related Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

0 g/Kg ethanol +/- 30% nitrous oxide

Group Type PLACEBO_COMPARATOR

30% Nitrous oxide

Intervention Type DRUG

0 g/Kg ethanol

Intervention Type OTHER

0.25 g/Kg ethanol +/- 30% nitrous oxide

Group Type ACTIVE_COMPARATOR

30% Nitrous oxide

Intervention Type DRUG

0.25 g/Kg ethanol

Intervention Type OTHER

0.5 g/Kg ethanol +/- 30% nitrous oxide

Group Type ACTIVE_COMPARATOR

30% Nitrous oxide

Intervention Type DRUG

0.5 g/KG ethanol

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

30% Nitrous oxide

Intervention Type DRUG

0.25 g/Kg ethanol

Intervention Type OTHER

0.5 g/KG ethanol

Intervention Type OTHER

0 g/Kg ethanol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Please contact site for information.
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Drug Abuse (NIDA)

NIH

Sponsor Role collaborator

University of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James Zacny, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago, Anesthesia & Critical Care

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01DA008391

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01-08391-15

Identifier Type: -

Identifier Source: secondary_id

NIDA-08391-15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Interactive Effects of IV Ethanol and IV Nicotine
NCT01814410 COMPLETED EARLY_PHASE1
Combined Pharmacotherapies for Alcoholism
NCT00768508 COMPLETED PHASE3
EtOH Interaction Study
NCT00887367 COMPLETED PHASE1
Oxytocin Treatment of Alcohol Dependence
NCT02251912 COMPLETED PHASE2
Cannabidiol for Alcohol Use Disorder
NCT03904849 WITHDRAWN PHASE1/PHASE2
Oxytocin in Alcohol Use Disorder
NCT02711189 WITHDRAWN PHASE1